Premier, CDC Partner on E-prediction of Bloodstream Infections | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Premier, CDC Partner on E-prediction of Bloodstream Infections

May 4, 2010
by root
| Reprints

The Premier healthcare alliance, headquartered in Charlotte, N.C., will collaborate with the U.S. Centers for Disease Control and Prevention (CDC) on a joint research initiative to test new technologies for predicting incidents of central-line associated bloodstream infections (CLABSIs), as well as to automate their reporting to the CDC’s National Healthcare Safety Network.

The initiative will analyze the specific traits of positive blood cultures across a subset of Premier’s more than 2,300 member hospitals to develop an automated electronic surveillance tool that could be used to accurately predict the presence of CLABSIs. The Chicago Prevention Epicenter at Stoger (Cook County) Hospital in Chicago will evaluate the tool in a real-world setting.

If successful, the CDC anticipates the tool could replace traditional surveillance methods for detecting CLABSIs, which are often dependent on time-consuming manual collection of clinical data and force resources to be spent on monitoring infection rates rather than preventing them.

According to the CDC, CLABIs affect approximately 250,000 patients in the U.S. each year, with additional costs ranging from $5,734 to $22,939 per patient.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More



KLAS Research: Small Hospitals’ Buying Decisions Impacting EMR Market Share

A new KLAS Research report tracks shifts in electronic medical record (EMR) vendor market share among acute care hospitals, and finds that smaller hospitals are seeking technology solutions that meet their needs and limited budgets, and these contracts are making a mark on the EMR market.

Survey: Majority of Providers Predict Success for New Generic Drug Company, Project Rx

Back in January, four health systems, in consultation with the VA, announced a collaboration to develop a new, not-for-profit generic drug company. A survey has found that 90 percent of providers say they would become customers of the new venture.

Personalized Medicine Awareness Low Among U.S. Adults, Survey Finds

Genetics and personalized medicine are not top of mind for the general public in the U.S., according to a recent survey from GenomeWeb and the Personalized Medicine Coalition.

Industry Organizations Praise Senate Passage of VA Mission Act

The U.S. Senate on Wednesday passed, by a vote of 92-5, a major Veterans Affairs (VA) reform bill that includes health IT-related provisions to improve health data exchange between VA healthcare providers and community care providers.

NIH Issues Funding Announcement for All of Us Genomic Research Program

The National Institutes of Health’s (NIH) “All of Us” Research Program has issued a funding announcement for genome centers to generate genotype and whole genome sequence data from participants’ biosamples.

MGMA: Physician Compensation Data Illustrates Nationwide PCP Shortage

Primary care physicians’ compensation rose by more than 10 percent over the past five years, representing an increase which is nearly double that of specialty physicians’ compensation over the same period, according to the Medical Group Management Association (MGMA).